General Drug Information and Indications

Alpha-2 adrenergic agonist for sedation, analgesia, and preanesthetic medication in horses, cattle, dogs, and cats; colic analgesia. Alpha-2 adrenergic agonist (xylazine HCl). Mechanism: agonist at alpha-2A and alpha-2B adrenergic receptors → inhibits presynaptic norepinephrine release and postsynaptic adrenergic signaling in the CNS → dose-dependent sedation, muscle relaxation, and analgesia (better for visceral than somatic pain). Initial peripheral vasoconstriction then bradycardia. Species-sensitive; horses require ~10× lower dose than cattle. Reversed by yohimbine. Key information DEA Schedule III. Alpha-2 agonist. Reversal: yohimbine (dogs, horses) or atipamezole (small animals). Cattle: 10x more sensitive — reduce dose significantly. Do not use as sole analgesic for painful procedures. Causes vomiting in cats — useful diagnostic tool. Avoid in animals with cardiac disease.

How to Give this Medication

IV (horses): administer slowly into jugular vein — full effect in 2–5 min. IM (horses): onset 10–20 min. Cattle: administer IM at 1/10th equine dose. Dogs/cats: IM or SQ. Have reversal agent (yohimbine or atipamezole) available. Keep horse's head elevated during and after sedation. Store at room temperature; protect from light. If a dose is missed This medication is administered by a veterinarian or veterinary staff in a clinical setting. Missed doses are managed by your veterinary team — contact your veterinarian to reschedule.

Side Effects

Cardiovascular: bradycardia, AV block, initial hypertension then hypotension. Respiratory: rate/tidal volume reduction. GI: decreased motility (colic in horses, bloat in cattle). Diuresis (polyuria). Sweating (horses). Ataxia. Penile prolapse (horses — stallions). Hypoxemia (horses in lateral recumbency). Cattle: 10× more sensitive than horses — use cattle-specific doses. Reversible with yohimbine.

Precautions

For animals Cattle: 10× more sensitive than horses — use cattle-specific dose (typically 0.05–0.1 mg/kg IM). Horses: do not use in animals with cardiac disease or severe bradycardia. GI: ileus — do not use in horses with suspected obstruction. Monitor respiratory function. Reversal: yohimbine (dogs/cats/horses); atipamezole (dogs/cats). Not approved for use in food-producing animals. Use with caution in pregnant animals. For people handling this medication Wear gloves when handling. Potent alpha-2 agonist sedative — even small amounts can cause dangerous sedation and cardiovascular depression in humans. Avoid skin contact and accidental injection. If accidentally self-injected or if significant skin contact occurs, seek emergency medical attention immediately. Do not drive or operate machinery after handling. Keep out of reach of children.

Overdose

This is a veterinary emergency. Overdose causes profound sedation, respiratory depression, and cardiovascular collapse. Reversal agent (yohimbine) is available and must be administered by veterinary staff immediately.

Xylazine dosage forms

ProductStrengthFormSizeType
XYLAZINE 100 MG/ML INJECTABLE: XYLAZINE100 MG/MLInjectable1Commercial
XYLAZINE HCL 50 ML 100 MG/ML INJECTABLE100 MG/MLInjectable1Commercial

Sources

This information is provided for educational purposes and is not a substitute for advice from your veterinarian. Source: Merck Veterinary Manual (merckvetmanual.com); Plumb's Veterinary Drug Handbook (Plumb, D.C., app.plumbs.com)